| Literature DB >> 36071439 |
Carme Herranz1,2, Rubèn González-Colom2, Erik Baltaxe2,3, Nuria Seijas4, Maria Asenjo4, Maaike Hoedemakers5, David Nicolas4, Emmanuel Coloma4, Joaquim Fernandez2,4, Emili Vela6, Isaac Cano2, Maureen Rutten-van Mölken5, Josep Roca2,4, Carme Hernandez7,8.
Abstract
BACKGROUND: Applicability of comprehensive assessment of integrated care services in real world settings is an unmet need. To this end, a Triple Aim evaluation of Hospital at Home (HaH), as use case, was done. As ancillary aim, we explored use of the approach for monitoring the impact of adoption of integrated care at health system level in Catalonia (Spain).Entities:
Keywords: Chronic care; Health Delivery Assessment; Health Services Research; Hospital at Home; Implementation Science; Multiple Criteria Decision Analysis; Triple Aim
Mesh:
Year: 2022 PMID: 36071439 PMCID: PMC9454140 DOI: 10.1186/s12913-022-08496-z
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Fig. 1Distribution of hospital admissions during the study period. Five-hundred eighty-six first episodes of HaH admissions, directly from the Emergency Room (HaH-HA), were registered during the study period. A sample of 2.631 conventional hospitalizations was used to generate a usual care (UC) group, as described in the text. The entire intervention group, after propensity score matching (PSM), consisted of 441 HaH-HA patients that were compared with the corresponding matched controls (UC), as reported in (Carme H, Carme H, Erik B, Nuria S, Ruben G, Asenjo M, David N, Enric C, Fernandez J, Isaac C, Roca J. Assessment of Hospital Avoidance in a Real-World Setting: a Prospective Cohort Study, Submitted) During the study period, two-hundred consecutive HaH-HA patients were assessed with a Triple Aim approach to perform Multiple Criteria Decision Analysis (MCDA) that was finally done in 137 HaH-HA patients after PSM with a UC group. Comparisons between the entire HaH-HA population (n = 586), the CCA study (n = 441) and the current study (n = 137) are reported in Tables 1S-3S
Characteristics of the study groups after propensity score matching before admission and clinical outcomes after discharge
| Age (years), mean (SD)* | 72.42 (13.92) | 72.79 (15.37) | .836 |
| Gender (male), n (%)* | 80 (58.39) | 79 (57.66) | .902 |
| Gender (female), n (%)* | 57 (41.61) | 58 (42.34) | .902 |
| Rate of all-cause emergency room visit, mean (SD) | 1.85 (1.19) | 1.76 (1.23) | .231 |
| Rate of all-cause Hospital admissions, mean (SD)* | 1.45 (0.9) | 2.02 (1.54) | .171 |
| Rate of planned admissions, mean (SD) | 1.32 (0.67) | 1.67 (0.91) | .152 |
| Last visit (days) to outpatient clinic before admission, mean (SD) | 78.36 (86.09) | 78.07 (81.86) | .981 |
| Last hospitalisation (days) before admission, mean (SD) | 202.12 (108.21) | 222.25 (110.74) | .413 |
| Length of stay in days (total days per year), mean (total) | 11.45 (458) | 14.75 (590) | .408 |
| Intensive care unit stays, n (%) | 7 (12.10) | 4 (5.70) | .405 |
| Outpatient visits, mean (SD) | 6.14 (7.19) | 5.64 (5.55) | .604 |
| Outpatient visits, mean (SD) | 1.20 (0.63) | 1.25 (0.62) | .405 |
| € per year, mean (SD)* | 7,023.81 (9,478.93) | 8,138.43 (8,083.83) | .854 |
| GMA scoring, mean (SD)* | 27.93 (14.72) | 28.8 (18.74) | .872 |
| | 8.20 (4.70) | 7.74 (5.96) | .479 |
| | 0.72 | 0.75 | .792 |
| | 0 (0) | 0 (0) | 1 |
| All-cause Emergency Room visits, n (%) | 2 (1.46) | N/A | NA |
| All-cause In-Hospital re-admissions, n (%) | 4 (2.92) | N/A | NA |
| All-cause Emergency Room visits, n (%) | 5 (3.65) | 20 (14.6) | < .001 |
| Unplanned Hospital admissions, n (%) | 5 (3.65) | 15 (10.95) | .012 |
| Planned admissions, n (%) | 2 (1.46) | 9 (6.57) | .031 |
| Mortality, n(%) | 1 (0.73) | 1 (0.73) | 1 |
| | |||
| | |||
Legend. HaH-HA, Hospital al Home-Hospital Avoidance; UC, Usual Care; GMA, Adjusted Morbidity Groups scoring; N/A, not applicable
Raw data of the eight outcomes before the MCDA
| Enjoyment of life | ICECAP-O | 1–4 | 2.50 (0.89) | 2.48 (0.87) | .496 |
| Resilience | BRS | 6–30 | 20.52 (5.48) | 19.72 (5.99) | .278 |
| Physical functioning | SF-36 | 0–100 | 55.27 (35.43) | 45.45 (31.87) | .019 |
| Continuity of care | NCQ | 0–5 | 3.82 (1.20) | 3.30 (1.15) | < .001 |
| Psychological well-being | MHI-5 | 0–100 | 69.32 (23.52) | 68.07 (22.11) | .623 |
| Social participation | IPA | 0–24 | 7.13 (3.95) | 7.00 (3.77) | .768 |
| Person-centeredness | P3CEQ | 0–18 | 15.94 (2.95) | 14.62 (3.80) | .001 |
| Health care costs | € | 1,126.76 (226.17) | 2,346.33 (519.14) | < .001 | |
Results expressed as mean (standard deviation). Questionnaires used for the MCDA (Multiple Criteria Decision Analysis) and CCA (Cost Consequence Analysis) are indicated in the Methods section. HaH-HA, (Hospital at Home-Hospital Avoidance); UC, Usual Care
Overall scores of the multiple criteria decision analysis (MCDA)
| Enjoyment of life | 0.22 | 0.71 | 0.71 | 0.15 | 0.15 |
| Resilience | 0.13 | 0.72 | 0.69 | 0.09 | 0.09 |
| Physical functioning | 0.12 | 0.77 | 0.64 | 0.09 | 0.07 |
| Continuity of care | 0.15 | 0.75 | 0.66 | 0.11 | 0.10 |
| Psychological well-being | 0.14 | 0.71 | 0.70 | 0.10 | 0.10 |
| Social participation | 0.11 | 0.72 | 0.70 | 0.08 | 0.08 |
| Person-centeredness | 0.09 | 0.74 | 0.67 | 0.07 | 0.06 |
| Health care costs | 0.05 | 0.87 | 0.49 | 0.04 | 0.02 |
Criteria/Outcomes: 8 outcomes categories assessed in the MCDA at 30 days after discharge; Relative weights: pooled weights of all five stakeholder groups; Standardized performance: Overall scoring for each outcome, HaH-HA: Hospital at Home-Hospital Avoidance, UC: Usual Care; Weighted aggregation: Standardized performance times corresponding relative weight. HaH-HA, Hospital at Home-Hospital Avoidance; UC, Usual Care; Overall value score: mean overall scores for HaH-HA and UC; 95% Uncertainty Interval; Percentage HaH-HA > UC, percentage of iterations in the Monte Carlo simulation showing higher overall value scores in HaH-HA than UC.
Fig. 2Sensitivity analysis of MCDA with DCE weights based on a Bootstrap analysis (1,000 iterations) of the MCDA overall score between hospital avoidance (HaH-HA) (green) and usual care (UC) (red) groups. In each iteration, the values of the eight outcomes considered in the MCDA were weighted according to the DCE results and subsequently summed to obtain a single overall value score. The panels show the mean overall value score across all bootstrap iterations (set to 1000) and their 95% Uncertainty Intervals (UI) for HaH-HA and UC and for each stakeholder group: A) Patients; B) Carers; C) Professionals; D) Payers + Policy Makers. The four panels show no overlap between intervention and control groups along the bootstrap replications
Fig. 3Quality of chronic care in the study areas